Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.38.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
N/ASYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.357SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.177.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-18702.5Singapore
A.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.530SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.17.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.2.75.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.570SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.633SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.136SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAYSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAESYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.467SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.484SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.476SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
A.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.404SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DJ.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.73SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BR.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.75.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAKSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAASYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.109SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.361SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.417SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.36.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.319SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.182SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.430SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.331SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.112.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used